FDA label

What is Xhance used for?

Xhance contains fluticasone propionate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label for Xhance lists 2 uses: Chronic Rhinosinusitis with Nasal Polyps; Chronic Rhinosinusitis without Nasal Polyps.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Xhance?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Xhance, spray, metered

Indications and Usage, quoted from the label by Paratek Pharmaceuticals, Inc. (NDA209022). Cross-references to other label sections are left out.

Chronic Rhinosinusitis with Nasal Polyps

XHANCE is indicated for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults.

Chronic Rhinosinusitis without Nasal Polyps

XHANCE is indicated for the treatment of chronic rhinosinusitis without nasal polyps (CRSsNP) in adults.

Source: DailyMed label, set id 44fcea33-8cfa-3a5c-e063-6394a90aafb2, version 2, effective May 19, 2026. NDC 71715-003, one of 2 listings for this product.

Questions

What is Xhance used for?

The FDA label for Xhance lists 2 uses: Chronic Rhinosinusitis with Nasal Polyps; Chronic Rhinosinusitis without Nasal Polyps.

What drug class is Xhance?

FDA lists fluticasone propionate in the Corticosteroid established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Xhance

Try it on your own data today.

Free to start. Most teams are using it the same day.